Featured Research

from universities, journals, and other organizations

Regenerative Medicine Seen As Means To Repair Wounded Warriors

Date:
April 23, 2008
Source:
U.S. Department of Defense
Summary:
The U.S. Defense Department has launched a five-year, Army-led cooperative effort to leverage cutting-edge medical technology to develop new ways to assist servicemembers who've suffered severe, disfiguring wounds during their wartime service. A key component of the initiative is to harness stem cell research and technology in finding innovative ways to use a patient's natural cellular structure to reconstruct new skin, muscles and tendons, and even ears, noses and fingers.

U.S. Army Surgeon General Lt. Gen. Eric Schoomaker explains, during an April 17, 2008 Pentagon press conference, how researchers are growing a new ear for a badly burned Marine using stem cells from his own body. This is one area of advanced treatment being explored by the new Armed Forces Institute of Regenerative Medicine.
Credit: Defense Dept. photo by R. D. Ward

The U.S. Defense Department has launched a five-year, Army-led cooperative effort to leverage cutting-edge medical technology to develop new ways to assist servicemembers who’ve suffered severe, disfiguring wounds during their wartime service.

The newly established Armed Forces Institute of Regenerative Medicine, known by the acronym AFIRM, will serve as the military’s operational agency for the effort, Dr. S. Ward Casscells, the assistant secretary of defense for health affairs, told reporters at a Pentagon news conference.

A key component of the initiative is to harness stem cell research and technology in finding innovative ways to use a patient’s natural cellular structure to reconstruct new skin, muscles and tendons, and even ears, noses and fingers, Casscells said.

Just more than 900 U.S. servicemembers have undergone amputations of some kind due to injuries suffered in wartime service in Afghanistan or Iraq, Casscells said. Other troops have been badly burned or suffered spinal cord injuries or significant vision loss.

“Getting these people up to where they are functioning and reintegrated, employed, (and) able to help their families and be fully participating members of society” is the task at hand in which AFIRM will play a major role, Casscells said.

AFIRM will fall under the auspices of the U.S. Army Medical Research and Material Command, based at Fort Detrick, Md., and it also will work in conjunction with U.S. Army Institute of Surgical Research, in San Antonio.

The Medical Research and Material Command is the Army’s lead medical research, development and related-material acquisition agency. It comes under U.S. Army Medical Command, which is led by Lt. Gen. Eric B. Schoomaker, the Army’s surgeon general. Schoomaker accompanied Casscells at the news conference.

“The cells that we’re talking about actually exist in our bodies today,” Schoomaker pointed out. “We, even as adults, possess in our bodies small quantities of cells which have the potential, under the right kind of stimulation, to become any one of a number of different kinds of cells.

For example, Schoomaker said, the human body routinely regenerates bone marrow or liver cells.

AFIRM will have an overall budget of about $250 million for the initial five-year period, of which about $80 million will be provided by the Defense Department, Schoomaker said. Other program funding will be provided by the National Institutes of Health, in Bethesda, Md., the Department of Veterans Affairs, and local public and private matching funding.

Rutgers University, in N.J.; Wake Forest University, in N.C.; and the University of Pittsburgh also will participate in the initiative.

Dr. Anthony Atala, a surgeon and director of the Institute for Regenerative Medicine at Wake Forest, also attended the news conference. Atala’s current research keys on growing new human cells and tissue.

“All the parts of your body, tissues and organs, have a natural repository of cells that are ready to replicate when an injury occurs,” Atala told reporters.

Medical technicians now can select cells from human donors and, through a series of scientific processes, can “regrow” new tissue, Atala said.

“Then, you can plant that (regenerated tissue) back into the same patient, thus avoiding rejection,” Atala said.

Special techniques are being developed to employ regrown tissue in the fabrication of new muscles and tendons, Atala observed, or for the repair/replacement of damaged or missing extremities such as noses, ears and fingers.

Continued advancement in regenerative medicine would greatly benefit those servicemembers and veterans who’ve been severely scarred by war, Schoomaker said.

The three-star general cited animals like salamanders that can regrow lost tails or limbs. “Why can’t a mammal do the same thing?” he asked.


Story Source:

The above story is based on materials provided by U.S. Department of Defense. The original article was written by By Gerry J. Gilmore, American Forces Press Service. Note: Materials may be edited for content and length.


Cite This Page:

U.S. Department of Defense. "Regenerative Medicine Seen As Means To Repair Wounded Warriors." ScienceDaily. ScienceDaily, 23 April 2008. <www.sciencedaily.com/releases/2008/04/080422134702.htm>.
U.S. Department of Defense. (2008, April 23). Regenerative Medicine Seen As Means To Repair Wounded Warriors. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2008/04/080422134702.htm
U.S. Department of Defense. "Regenerative Medicine Seen As Means To Repair Wounded Warriors." ScienceDaily. www.sciencedaily.com/releases/2008/04/080422134702.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins